The future of life sciences is in data, and no firm is better situated than MoFo to understand the convergence of the life sciences industry and data analytics. Our Life Sciences Group advises clients on all legal aspects of life sciences data analytics businesses, including patenting software and AI-related life science inventions, licensing of data, providing counsel on the steps to ensure data privacy and ethical use of data, and guiding clients through the FDA approval process for data-driven diagnostic assays and medical devices. Our Life Sciences Group is a unique amalgamation of lawyers with extensive training in biotechnology and pharmaceuticals coupled with the cutting-edge application of data science. We apply this combination for our digital health, biotechnology, medical device, pharmaceutical, and agtech clients, bridging the gap between the law and science.
Routinely recognized as a leading firm for life sciences and technology, we are uniquely qualified to understand how data is being used to gain insights and drive innovation in agriculture, medicine, and clinical research. We help our clients embrace analytics-driven insights and apply data-driven decision making to the most pressing issues they face in the marketplace, and we apply our fluency in data science and analytics to support our client’s goals to track execution against strategy.
We counsel more than 500 companies and research institutions, as well as the venture capital funds and investment banks that finance them, around the globe. We maintain an impressive reputation by representing leading life sciences and healthcare companies, as well as the investors that are driving the hottest innovations – from the world’s largest and most influential companies to ground-breaking entrepreneurs and start-ups. Across legal disciplines, our Life Sciences team works with companies at every phase of their growth cycle, from conception to commercialization and exit, vigilantly protecting and enforcing our clients’ rights.
U.S. News – Best Lawyers® Best Law Firms 2019 National: Biotechnology Law (Tier 1) Los Angeles: Biotechnology Law (Tier 1) San Diego: Biotechnology Law (Tier 1) San Francisco: Biotechnology Law (Tier 1)
Chambers Global 2018 Global: Life Sciences Asia-Pacific Region: Life Sciences
Chambers USA 2018 National: Life Sciences California: Life Sciences
Chambers Asia Pacific 2019 Asia-Pacific Region: Life Sciences Life Sciences (International Firms): China Life Sciences (International Firms): Japan
Managing Intellectual Property Shortlist 2018 United States: Life Sciences IP Litigation
LMG Life Sciences 2017 Hatch-Waxman Patent Litigation Patent Prosecution (Highly Recommended) Patent Strategy and Management (Highly Recommended)
Here is what they say about us:
“Well placed, thanks to its global network, to provide IP and corporate support to biotech companies and leading investors on joint venture, funding, patent litigation and enforcement, and licensing issues in the life sciences sphere.” (Chambers Global 2018)
“noted for core technology expertise within the [life sciences] sector and an impressive transactional capability across the Asia-Pacific region.” (Chambers Global 2018)
“Top-notch lawyers who are client-focused and business savvy” (Chambers USA 2018)
“Solid teams in the USA and Asia offer broad expertise in transactions and IP work. Noted for its capabilities in capital markets transactions and is well known for patent matters, providing specialists for litigation and prosecution. Assists key international clients in the life sciences sector.” (Chambers Global 2017)
“Clients say cases are run efficiently, effectively, with consideration of the budget and ultimately end up in an agreeable outcome.” (Chambers USA 2017)
Read the latest legal and business insights impacting the global life sciences community
“Handles significant corporate transactions for leading life sciences clients, including M&A, strategic partnerships and IPOs. Also offers outstanding expertise in IP licensing and enforcement matters in the USA, with strong support from teams in Japan and China.” (Chambers Global )
Recognized by U.S. News – Best Lawyers® Best Law Firms 2018 as a Tier 1 firm in biotechnology law.
©1996-2019 Morrison & Foerster LLP. All rights reserved.